TMB-ADC

N/A

Report date: 2025/01/26 16:06:49

Base Information

Drug NameTMB-ADC

Drug Alias NameHDAC inhibitor-ibalizumab conjugate (TaiMed Biologics)antibody drug conjugate (TaiMed Biologics)TMB-ADC

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionHistone deacetylase inhibitors

TargetsHistone deacetylase

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTaimed Biologics Inc

China Registration ClassN/A

Develop Information

Active CompaniesTaimed Biologics Inc

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A